Effect of Staphylococcus Aureus and Streptococcus beta-haemolytic Supernatants’ on Leishmania Major Promastigotes Viability: An In Vitro Study

Publish Year: 1396
نوع سند: مقاله ژورنالی
زبان: English
View: 50

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_JIML-4-3_006

تاریخ نمایه سازی: 14 مرداد 1402

Abstract:

Background and Aims: Leishmaniasis is an intracellular protozoan- parasitic disease, the common vector of transmission. Both zoonotic and anthroponotic cutaneous leishmaniasis (CL) are endemic in different foci. With regard to the cutaneous form, ۱.۰-۱.۵ million cases were reported annually with ۹۰% of the cases. Although antimony-containing compounds that are the main drugs used to treat Leishmaniasis has been recommended for CL treatment by the World Health Organization, but there are some restrictions in this case, including high expense, side effects, frequent injections need, and incomplete efficacy. The current research was conducted the effect of Staphylococcus aureus and Streptococcus beta-haemolytic Supernatants’ on Leishmania major promastigotes (PMs) viability: an in vitro study. Materials and Methods: Staphylococcus aureus and Streptococcus beta-haemolytic cultured for preparing supernatant, then Leishmania (L) major strain [MRHO/IR/۷۵/ER] PMs cultured in Novy-Nicolle-Mac Neal (NNN) and roswell park memorial institute ۱۶۴۰ media. The cell proliferation of enzyme-linked immunosorbent assay, BrdU (Chemiluminescent) was performed as described by Roche Diagnostics. The mean of the viability PMs of Leishmania (L) major strain [MRHO/IR/۷۵/ER] in culture according to Staphylococcus aureus and Streptococcus beta-haemolytic supernatant, Glocantime concentrations and in the control group (Glocantime) was obtained. Results: It was shown that there was a statistical significant difference among Staphylococcus aureus and Streptococcus beta-haemolytic supernatant inhibits growth of Leishmania (L) major strain [MRHO/IR/۷۵/ER] PMs with the control group (p<۰.۰۵) . Conclusions: These exciting results suggest that Staphylococcus aureus and Streptococcus beta-haemolytic Supernatants have significant therapeutic potential as novel anti-leishmanial.

Authors

علی فتاحی بافقی

Department of Parasitology and Mycology, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

بنفشه گودیانی

Department of Pharmacy, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

محمد حسین مصدق

School of Pharmacy, Shahid Sadoughi University of Medical Sciences, Shohadaye Gomnam Blvd, Safaeeyeh, Yazd, Iran

عارفه دهقانی

School of Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

مریم ساده

Department of Laboratory Technology, Faculty of Paramedicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • . Nadim A, Faghih M. The epidemiology of cutaneous leishmaniasis ...
  • . World Health Organization. The Leishmaniasis and Leishmania/HIV Co-Infections. WHO ...
  • . Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander ...
  • . Hepburn NC. Cutaneous leishmaniasis. Clin Exp Dermatol. ۲۰۰۰; ۲۵(۹): ...
  • . Iranshahi M, Arfa P, Ramezani M, Jaafari MR, Sadeghian ...
  • . Fatahi Bafghi A, Bagheri SM, Hejazian SH. Antileishmanial activity ...
  • . Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic ...
  • . Finegold SM, Martin WJ. Diagnostic Microbiology ۷th ed. London: ...
  • . Edrissian GH, Mohammadi M, Kanani A, Afshar A, Hafezi ...
  • . Vera LA, Santos JB, Macedo VO, de Magalhaes AV, ...
  • . O’Meara SM, Cullum NA, Majid M, Sheldon TA. Systematic ...
  • . Ziaie H, Sadeghian G, Isolation of bacteria causing secondary ...
  • . lrajhi AA, Ibrahim EA, De Vol EB, Khairat M, ...
  • . Desjeux P. Worldwide increasing risk factors for leishmaniasis. Med ...
  • . Tarcisio M. Andrade, Edgar M. Carvalho and Heonir Rocha, ...
  • . Ziaie H, Sadeghian G. Isolation of bacteria causing secondary ...
  • . Ziaei H, Sadeghian G, Hejazi SH. Distribution frequency of ...
  • . Sadeghian G, Ziaei H, Bidabadi LS, Bagh-baderani AZ. Decreased ...
  • . Van Der Vliet D, Le Guern AS, Freitag S, ...
  • . Charlotte Frydenlund Michelsen et al, Staphylococcus aureus Alters Growth ...
  • . Ihaka R, Gentleman RR. Development Core Team. R: A ...
  • . Fattahi Bafghi A, Shahcheraghi SH, Nematollahi S. Comparison of ...
  • . Mohebali M. Glucantime-resistant Leishmania tropica isolated from Iranian patients ...
  • . Fatahi Bafghi A, Daghighi M, Daliri K, Jebali A. ...
  • . Fatahi Bafghi A, Jebali A, Daliri K. Silica nanowire ...
  • . Fattahi Bafghi A, Vahidi AR, Anvari MH, Barzegar K, ...
  • . Fattahi Bafghi A, Noorbala M, Noorbala MT, Aghabagheri M. ...
  • . Miriam A. Lynn, Jason Kindrachuk,۲ Alexandra K. Marr, Håvard ...
  • . Fabri RL, Nogueira MS, Braga FG, Coimbra ES, Scio ...
  • . Santana DB, Correia da Costa R, Araújo RM, de ...
  • . Xiao-qing Wei, Bernard P Leung, Wanda Niedbala, David Piedrafita, ...
  • . Jiazhang Qiu, Dacheng Wang, Hua Xiang, Haihua Feng, Youshuai ...
  • نمایش کامل مراجع